The page is the record's research on the issuer — no analyst, no rating, no view.

NFL BIOSCIENCES S.A. (FR0014003XT0) — research page

FR · fr-cm-kg/ALXP/FR0014003XT0 · as of 2026-11-06

Identity and listing

The issuer is NFL BIOSCIENCES S.A., listed on Euronext Growth Paris under ticker FR0014003XT0, ISIN FR0014003XT0, LEI 9695006VJWNTN4UNHA27. Its security type is Corporate, its sector is NAF 72.19Z, and its jurisdiction is France (RCS-registered SA à conseil d'administration (s.a.i.)). The segment is not on the record. Status on the record date of 2026-11-06 is listed, not halted.

fieldvaluesource · read date
nameNFL BIOSCIENCES S.A.source · 2026-11-06
exchangeEuronext Growth Parissource · 2026-11-06
tickerFR0014003XT0source · 2026-11-06
ISINFR0014003XT0source · 2026-11-06
LEI9695006VJWNTN4UNHA27source · 2026-11-09
security typeCorporatesource · 2026-11-06
segmentnot on the record
sectorNAF 72.19Zsource · 2026-11-06
jurisdictionFrance (RCS-registered SA à conseil d'administration (s.a.i.))source · 2026-11-06
statuslisted, not haltedsource · 2026-11-09

The disclosure read

The record holds 12 filings across 11 filing days in the window 2025-11-06 to 2026-11-06, of which 10 are newswire releases and 2 are results. The median gap between filing days is 25.5 days. The latest filing is dated 2026-10-30, a newswire release, 7 days before the record date. The exchange median is 17.8 days cadence across 258 issuers, with 5.0 median filings and 8 days median latency. The sector median is 8.0 days cadence across 17 issuers, with 17 median filings and 7 days median latency.

filingsmedian gap between filing daysdays from latest filing to as-of
this issuer1225.57
exchange median: Euronext Growth Paris (258 issuers)517.88
sector median: NAF 72.19Z (17 issuers)1787
datetypecategoryfiling
2026-10-30newswire_releaseNFL Biosciences will participate in the BIO-Europe 2026 ...
2026-10-23resultsNFL Biosciences Reports Its 2026 Half-Year Results and ...
2026-10-22resultsNFL Biosciences Reports Its 2026 Half-Year Results and ...
2026-10-22newswire_releaseNFL Biosciences Receives Regulatory Approval to Begin ...
2026-10-06newswire_releaseNFL Biosciences: Progress Update Ahead of Upcoming ...

window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor of record is not on the record, and the auditor's location is not on the record. Auditor changes are not on the record, because the market's register has no lifecycle type map yet.

Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag is clear: listed, not halted.

Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/fr/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.

rule acm-68000/fr/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's investor-relations page names one research house: Invest Securities.

research houseanalystsource · read date
Invest Securitiesissuer page · 2026-11-12

Open research

The record holds one openly published research note, by Invest Securities, dated 2021-09-17.

datepublishernotekind
2021-09-17Invest SecuritiesNFL BIOSCIENCESissuer-sponsored

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

licensorentitlementtitledatesource
none loaded

As-of depth

The market's vintage is not sealed, so no sealed years hold this issuer, no earliest sealed date is on the record, and the live record start is not on the record.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1
https://registers.esma.europa.eu/publication/searchRegister?core=esma_registers_firds (identity.exchange)
10.2
https://recherche-entreprises.api.gouv.fr/search?q=494700321 (identity.jurisdiction)
10.3
https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
10.4
https://mcp.fr-cm-kg.ai/events/ALXP/FR0014003XT0 (the disclosure lines)
10.5
https://live.euronext.com/en/ajax/haltedInstrument/getAjax/current (the halt flag)
10.6
https://mcp.fr-cm-kg.ai/book/aio.json (the orderability chapter)
10.7
https://www.nflbiosciences.com/en/laction-nfl-biosciences/ (coverage)
10.8
https://www.nflbiosciences.com/wp-content/uploads/2023/09/20210917-Flash-Invest-ENG.pdf (open research)
10.9
https://mcp.fr-cm-kg.ai/record/ALXP/FR0014003XT0 (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"FR0014003XT0"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:2dfcbfbfc34b7100.